Literature DB >> 19297548

Progressive polyuria without vasopressin neuron loss in a mouse model for familial neurohypophysial diabetes insipidus.

Masayuki Hayashi1, Hiroshi Arima, Noriyuki Ozaki, Yoshiaki Morishita, Maiko Hiroi, Nobuaki Ozaki, Hiroshi Nagasaki, Noriaki Kinoshita, Masatsugu Ueda, Akira Shiota, Yutaka Oiso.   

Abstract

Familial neurohypophysial diabetes insipidus (FNDI), an autosomal dominant disorder, is mostly caused by mutations in the gene of neurophysin II (NPII), the carrier protein of arginine vasopressin (AVP). Previous studies suggest that loss of AVP neurons might be the cause of polyuria in FNDI. Here we analyzed knockin mice expressing mutant NPII that causes FNDI in humans. The heterozygous mice manifested progressive polyuria as do patients with FNDI. Immunohistochemical analyses revealed that inclusion bodies that were not immunostained with antibodies for mutant NPII, normal NPII, or AVP were present in the AVP cells in the supraoptic nucleus (SON), and that the size of inclusion bodies gradually increased in parallel with the increases in urine volume. Electron microscopic analyses showed that aggregates existed in the endoplasmic reticulum (ER) as well as in the nucleus of AVP neurons in 1-mo-old heterozygous mice. At 12 mo, dilated ER filled with aggregates occupied the cytoplasm of AVP cells, while few aggregates were found in the nucleus. Analyses with in situ hybridization revealed that expression of AVP mRNA was significantly decreased in the SON in the heterozygous mice compared with that in wild-type mice. Counting cells expressing AVP mRNA in the SON indicated that polyuria had progressed substantially in the absence of neuronal loss. These data suggest that cell death is not the primary cause of polyuria in FNDI, and that the aggregates accumulated in the ER might be involved in the dysfunction of AVP neurons that lead to the progressive polyuria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297548     DOI: 10.1152/ajpregu.00034.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  14 in total

Review 1.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

Review 2.  Lessons from animal models of endocrine disorders caused by defects of protein folding in the secretory pathway.

Authors:  Yoshiaki Morishita; Peter Arvan
Journal:  Mol Cell Endocrinol       Date:  2019-10-09       Impact factor: 4.102

3.  ER-associated degradation is required for vasopressin prohormone processing and systemic water homeostasis.

Authors:  Guojun Shi; Diane RM Somlo; Geun Hyang Kim; Cristina Prescianotto-Baschong; Shengyi Sun; Nicole Beuret; Qiaoming Long; Jonas Rutishauser; Peter Arvan; Martin Spiess; Ling Qi
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

4.  AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus.

Authors:  Doga Turkkahraman; Emel Saglar; Tugce Karaduman; Hatice Mergen
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

5.  A novel AVP gene mutation in a Turkish family with neurohypophyseal diabetes insipidus.

Authors:  M Ilhan; N O Tiryakioglu; O Karaman; E Coskunpinar; R S Yildiz; S Turgut; D Tiryakioglu; H Toprak; E Tasan
Journal:  J Endocrinol Invest       Date:  2015-07-25       Impact factor: 4.256

6.  A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.

Authors:  Camilla Birkegaard; Jane H Christensen; Alberto Falorni; Stefania Marzotti; Viviana Minarelli; Niels Gregersen; Søren Rittig
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 7.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

8.  Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene.

Authors:  Maria Inês Alvelos; Ângela Francisco; Leonor Gomes; Isabel Paiva; Miguel Melo; Pedro Marques; Susana Gama-de-Sousa; Sofia Carreiro; Telma Quintela; Isabel Gonçalves; Manuel Carlos Lemos
Journal:  Pituitary       Date:  2021-01-12       Impact factor: 4.107

9.  Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus.

Authors:  D Hagiwara; H Arima; Y Morishita; L Wenjun; Y Azuma; Y Ito; H Suga; M Goto; R Banno; Y Sugimura; A Shiota; N Asai; M Takahashi; Y Oiso
Journal:  Cell Death Dis       Date:  2014-03-27       Impact factor: 8.469

Review 10.  Central diabetes insipidus.

Authors:  Hiroshi Arima; Yoshinori Azuma; Yoshiaki Morishita; Daisuke Hagiwara
Journal:  Nagoya J Med Sci       Date:  2016-12       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.